Heart Failure Reviews
Overview
Heart Failure Reviews is a comprehensive and authoritative journal that focuses on the latest advancements in heart failure research and clinical practice. It provides in-depth reviews, original articles, and expert opinions on various aspects of heart failure, including pathophysiology, diagnosis, treatment, and management strategies. This journal serves as a valuable resource for healthcare professionals, researchers, and students interested in staying updated with the rapidly evolving field of heart failure.
Details
Details
Abbr.
Heart Fail Rev
Start
1996
End
Continuing
Frequency
Quarterly
p-ISSN
1382-4147
e-ISSN
1573-7322
Country
United States
Language
English
Metrics
Metrics
h-index / Ranks: 3170
99
SJR / Ranks: 2796
1208
CiteScore / Ranks: 1834
8.90
JIF / Ranks: 1820
4.6
Recent Articles
1.
Pecchia B, Samuel R, Shah V, Newman E, Gibson G
Heart Fail Rev
. 2025 Mar;
PMID: 40080287
Exercise intolerance is a well-established symptom of heart failure with preserved ejection fraction (HFpEF) and is associated with impaired quality of life and worse clinical outcomes. Historically attributed to diastolic...
2.
Ndakotsu A, Nduka T, Agrawal S, Asuka E
Heart Fail Rev
. 2025 Mar;
PMID: 40069401
Cirrhotic cardiomyopathy (CCM) is a cardiac dysfunction linked to chronic liver disease, primarily characterized by impaired cardiac response to stress, despite normal baseline function. It presents with both systolic and...
3.
Ang S, Chia J, Mukherjee D
Heart Fail Rev
. 2025 Mar;
PMID: 40056371
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, life-threatening disease caused by the pathological deposition of misfolded transthyretin (TTR) protein in the myocardium, leading to restrictive cardiomyopathy and heart failure. While...
4.
Kittipibul V, Ambrosy A, Greene S
Heart Fail Rev
. 2025 Feb;
PMID: 39998729
Systemic inflammation is considered one of the key physiological drivers in heart failure with preserved ejection fraction (HFpEF) and is associated with worse outcomes. While inflammation has been investigated as...
5.
Candida F, Rui B, Fatima F, Brenda M, Joana P, Moraes Sarmento P, et al.
Heart Fail Rev
. 2025 Feb;
PMID: 39976853
For most patients with chronic heart failure (HF), the clinical course of the disease includes periods of apparent clinical stability punctuated by episodes of clinical deterioration with worsening signs and...
6.
Mecinaj A, Vinje-Jakobsen V, Ngo D, Sverdlov A, Myhre P
Heart Fail Rev
. 2025 Feb;
PMID: 39960554
This mini-review highlights the results of the SARAH trial, which evaluated the efficacy of sacubitril/valsartan in preventing subclinical cardiac dysfunction in patients undergoing anthracycline-based chemotherapy. The trial demonstrated a significant...
7.
Zheng J
Heart Fail Rev
. 2025 Feb;
PMID: 39951195
This focused review examines the results of the PHARM-HF A&F Study, a randomized trial evaluating audit and feedback interventions to optimize heart failure medication management among primary care pharmacists in...
8.
Alyaydin E, Gotschy A, Parianos D, Nagele M, Tudorache I, Flammer A, et al.
Heart Fail Rev
. 2025 Feb;
PMID: 39945978
Tricuspid regurgitation (TR) is a common valvular dysfunction following heart transplantation (HT), with reported prevalence rates ranging from 19 to 84%, primarily depending on the duration of follow-up. Its etiology...
9.
Davison B, Abbate A, Cotter G, Pascual-Figal D, Van Tassell B, Villota J, et al.
Heart Fail Rev
. 2025 Feb;
PMID: 39939545
We examined current evidence regarding the effects of anti-inflammatory therapies in patients with acute heart failure (AHF) on the risk of cardiovascular outcomes, inflammatory markers, natriuretic peptides, and renal function....
10.
Aimo A, Ferrari Chen Y, Castiglione V, Passino C, Genovesi D, Giorgetti A, et al.
Heart Fail Rev
. 2025 Feb;
PMID: 39924609
The increasing recognition of cardiac amyloidosis (CA) as a cause of heart failure, coupled with advancements in therapeutic options, has underscored the need for early detection. Positron emission tomography (PET)...